Category: seventh

  • Teva reports seventh straight quarter of growth

    Teva Pharmaceutical Industries Limited (New York Stock Exchange: Tifa; level: Tifa It ended the third quarter with revenue of $4.33 billion and non-GAAP earnings per share of $0.69, beating the consensus of analysts who expected revenue of $4.12 billion and $0.66 per share. The share price rose by 7% on…

  • Teva reports seventh straight quarter of growth

    Teva Pharmaceutical Industries Limited (New York Stock Exchange: Tifa; level: Tifa It ended the third quarter with revenue of $4.33 billion and non-GAAP earnings per share of $0.69, beating the consensus of analysts who expected revenue of $4.12 billion and $0.66 per share. The share price rose by 7% on…